Loading provider…
Loading provider…
Surgical Critical Care Physician in Newark, DE
NPI: 1093033482Primary Employer
Christianacare Family Medical Center
christianacare.org
HQ Phone
Get DO Luis's Phone Numberphone_androidMobile
Get DO Luis's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
DE State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 118 | 244 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 89 | 89 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 41 | 42 |
| 4 | 99285Emergency department visit, problem with significant threat to life or function | 27 | 27 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 23 | 29 |
Authors: Gallagher, Kathy, Desai, Harsh K, Alberto, Emily C, Cardenas, Luis
Journal: Wound Manag Prev
Authors: Gahlot, Sweta, Dappozze, Frederic, Singh, Deobrat, Ahuja, Rajeev, Cardenas, Luis, Burel, Laurence, Amans, David, Guillard, Chantal, Mishra, Shashank
Journal: Dalton Trans
Corrigendum: Synergy between Metallic and Oxidized Pt Sites Unravelled during Room Temperature CO Oxidation on Pt/Ceria.
Authors: Frederic Meunier, Luis Cardenas, Helena Kaper, Břetislav Šmíd, Mykhailo Vorokhta, Rémi Grosjean, Daniel Aubert, Kassiogé Dembélé, Thomas Lunkenbein
Publication Date: 2021-03-22
Lead Sponsor: University of Maryland, Baltimore
Collaborators: United States Department of Defense, US Department of Veterans Affairs Cooperative Studies Program, KAI Research
Intervention / Treatment: DEVICE: Hypothermia, DRUG: Neuromuscular Blocking Agents, DEVICE: Standard of care
Lead Sponsor: Atox Bio Ltd
Collaborators: Biomedical Advanced Research and Development Authority
Intervention / Treatment: DRUG: AB103 0.5 mg/kg, OTHER: NaCl 0.9%